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Septo-optic dysplasia (SOD) is a congenital brain
anomaly that results in pituitary, optic nerve, and
midline forebrain defects. The etiology of SOD is
poorly understood, with the majority of cases being
sporadic. In rare instances, SOD is caused by muta-
tions in Sox2, Sox3, or Hesx1, but how this manifests
in disease is not entirely certain. We demonstrate
here that mouse embryos lacking Sonic hedgehog
(Shh) in the prospective hypothalamus exhibit key
features of SOD, including pituitary hypoplasia and
absence of the optic disc. The hypothalamic source
of Shh is required to maintain gene expression
boundaries along the anteroposterior and mediolat-
eral neural axes that are important for proper pitui-
tary and eye development, respectively. We further
reveal that Sox2 and Sox3 are dose-dependent regu-
lators of Shh transcription that directly bind and acti-
vate a long-range Shh forebrain enhancer. These
data indicate that reduced levels of Shh expression
in the hypothalamus cause SOD.
INTRODUCTION
Shh is a secreted protein that imparts patterns of growth and
identity to neuronal progenitors throughout ventral regions of
the developing central nervous system (CNS) (Dessaud et al.,
2008). For Shh to fulfill these functions, it must be expressed in
a temporally and spatially defined manner. Despite a detailed
understanding of the signal transduction pathway functioning
downstream of Shh, we still know relatively little of the genes
operating upstream in the pathway that regulate Shh transcrip-
tion in key signaling centers mediating CNS development (Des-
saud et al., 2008).
During early stages of brain development, Shh is expressed in
the prechordal plate, an axial mesendodermal tissue that
transiently underlies the anterior CNS (Echelard et al., 1993).
Shh signaling from the prechordal plate is necessary for the
separation of the cerebral hemispheres, eye fields, and otherDevelocraniofacial structures (Chiang et al., 1996). In humans, SHH
haploinsufficiency is the predominant cause of holoprosence-
phaly (HPE), a structural brain malformation syndrome, indi-
cating that the level of SHH expression in the prechordal plate
is important for proper forebrain and craniofacial development
(Roessler et al., 1996).
Prechordal plate derived signals also regionalize the ventral
forebrain (Shimamura and Rubenstein, 1997). In chick, the
combination of Shh and Bmp7 secreted from the prechordal
plate activate markers of hypothalamic identity within the over-
lying ventral diencephalon (Dale et al., 1997; Manning et al.,
2006). Once induced, the hypothalamus becomes a secondary
site of Shh expression (Echelard et al., 1993; Dale et al., 1997).
This early event in brain regionalization is critical for subsequent
functions of the hypothalamus and pituitary, which are often
compromised in HPE cases (Kauvar and Muenke, 2010).
However, due to the severity of the brain defects in Shh/
mouse embryos, it has been difficult to fully discern the function
of Shh in the hypothalamus from its earlier role in the prechordal
plate (Chiang et al., 1996).
Using a conditional gene targeting approach, we now demon-
strate thatmice lacking Shh in the hypothalamus exhibit a combi-
nation of hypothalamic, pituitary and eye defects that are more
consistent with a diagnosis of SOD, than they are with HPE.
Given the phenotypic similarities between hypothalamic Shh
mutants and mouse models of SOD (Kelberman and Dattani,
2008), we postulated that a reduction in Shh signaling from the
hypothalamus might underlie the pathogenesis of this disorder.
Indeed,Shh expression was downregulated in the hypothalamus
of Sox2 and Sox3 mutants, two mouse models of SOD (Kelber-
man et al., 2006; Rizzoti et al., 2004). Furthermore, we show
that Sox2 and Sox3 are direct regulators of a long-range Shh
forebrain enhancer. Our data suggest that SOD and HPE are
genetically distinct brain anomalies with partially overlapping
phenotypes that can be distinguished by the timing and location
of Shh downregulation.
RESULTS
The Hypothalamic Source of Shh Is Required for Proper
Pituitary Morphology
Shh expression in the ventral diencephalon of embryonic day (E)
10.5 mouse embryos is detected in two bilateral stripes on eitherpmental Cell 22, 585–596, March 13, 2012 ª2012 Elsevier Inc. 585
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orly, to the level of the optic vesicles anteriorly, at which point
Shh converges at the midline and extends into the preoptic
area (POA) at the base of the telencephalon (Figure S1A available
online). To address the function of the hypothalamic source of
Shh, we used an SBE2-cremouse line to conditionally inactivate
a floxed allele of Shh. SBE2, an upstream regulatory element
from Shh, was particularly advantageous for this purpose, as it
only activates cre transcription within Shh-expressing cells of
the hypothalamus (Jeong et al., 2006). Attenuation of Shh
expression was first apparent in both anterior and posterior
regions of the prospective hypothalamus at E9.0 (16 somite
stage) in SBE2-cre; Shhloxp/ embryos (hereafter referred to as
ShhDhyp, for deletion of Shh in the hypothalamus) (Figure S1B).
Complete abrogation of Shh from the SBE2 domain of ShhDhyp
embryos was observed at E9.5 (Figure S1C). At E12.5, Shh
continued to be absent from the ventral hypothalamus of
ShhDhyp embryos, but not other forebrain regions (Figures 1A
and 1D). Shh signaling activity, as measured by the expression
of Gli1, was greatly reduced in Shh-responsive cells within the
hypothalamus of ShhDhyp embryos (Figures 1B and 1E). This is
consistent with recent results demonstrating a requirement for
Shh in the formation of ventral hypothalamic nuclei (Szabo´
et al., 2009; Shimogori et al., 2010). The loss of neuroendocrine
and centrally projecting neurons in ShhDhyp embryos results, in
part, from altered dorsoventral patterning in the diencephalon
andwill be described elsewhere. Instead, our analysis of ShhDhyp
embryos focused on a unique aspect of Shh function, the regu-
lation of gene expression boundaries along the anteroposterior
axis of the hypothalamus.
The Nkx2.1 homeoprotein is expressed in the ventral hypo-
thalamus in response to Shh signaling from the prechordal plate
(Dale et al., 1997) (Figure 1C). Nkx2.1 staining was maintained in
ShhDhyp embryos (Figure 1F). This result, along with the observa-
tion that the cerebral hemispheres and eyes were appropriately
bifurcated in ShhDhyp embryos, suggests that Shh signaling
activity from the prechordal plate was not compromised in these
mutants (data not shown). However, we did observe an irregu-
larity in the development of the Nkx2.1+ infundibulum in ShhDhyp
embryos. The infundibulum evaginates from the ventral dien-
cephalon to form the posterior lobe of the pituitary (Zhu et al.,
2007). However, in ShhDhyp embryos, the infundibulum was
highly dysmorphic, failed to protrude correctly from the dien-
cephalon, and was shifted anteriorly within the brain (Figures
1C and 1F). Examination of Tbx2 confirmed the ectopic position
of the infundibulum in ShhDhyp embryos (Figures 1G and 1J). The
retrochiasmatic area of the hypothalamus (RCH) lies between
the Tbx2+ infundibulum posteriorly and the Foxg1+ POA anteri-
orly (Figure 1H). The distance between Tbx2 and Foxg1 was
greatly reduced in ShhDhyp mutants compared to control litter-
mates, and the RCH took on a thinner cellular morphology, which
is more characteristic of the infundibulum (Figures 1H and 1K).
Thus, anterior hypothalamic development, including the posi-
tioning of the posterior pituitary, was greatly compromised in
ShhDhyp embryos.
Anterior pituitary formation was also affected in ShhDhyp
mutants. Rathke’s pouch, the primordium of the anterior and
intermediate lobes of the pituitary, arises from a region of oral
ectoderm that invaginates in response to inductive cues from586 Developmental Cell 22, 585–596, March 13, 2012 ª2012 Elsevierthe infundibulum (Zhu et al., 2007). Lhx3 staining, which marks
Rathke’s pouch, revealed a duplicated invagination that failed
to pinch off from the oral ectoderm and, like the infundibulum,
was shifted anteriorly in the brain of ShhDhyp embryos (Figures 1I
and 1L and Figure S3A).
Shh Positions the Infundibulum by Opposing Posterior
Hypothalamic Signals
To understand the molecular basis of the pituitary phenotype in
ShhDhyp embryos, we interrogated genes expressed along the
anteroposterior axis of the hypothalamus at earlier stages of
development (Figure 2A). Previous studies implicated members
of the Bmp and Fgf families in the induction and growth of
Rathke’s pouch (Ericson et al., 1998; Treier et al., 1998; Takuma
et al., 1998). Bmp4 and Fgf10 are expressed in the ventral
midline of the posterior hypothalamus, including the infundib-
ulum (Figures 2A, 2B, and 2D). This contrasts with the expression
of Shh, Six6, and Tcf4, which mark the ventral midline of the
anterior hypothalamus, rostral to the infundibulum (Figures 2A,
2F, 2H, and 2J). In ShhDhyp mutants, the anterior limit of Bmp4
and Fgf10 expression extended into the RCH territory at the
expense of Shh and Six6 (Figures 2B–2I). Evidence in support
of this conclusion was gained by our observation that the
distance between the anterior extent of Fgf10 expression and
the optic recess, a fixed morphological landmark, was dra-
matically reduced in ShhDhyp mutants compared to control
littermates (Figures 2D and 2E). The area of expanded Fgf10
expression coincided roughly with where Shh and Six6 were
downregulated (Figures 2D–2I). The anterior expansion of
Bmp4was observed as early as E9.5, suggesting that it occurred
in direct response to the loss of Shh. Not all genes expressed in
the anterior hypothalamus were downregulated in ShhDhyp
embryos, as evidenced by the persistent expression of Tcf4 in
the RCH region (Figures 2J and 2K). Importantly, this finding
argues that the altered gene expression profile in the hypothal-
amus of ShhDhyp mutants does not result from the ablation of
anterior hypothalamic tissue, but instead is likely due to the
failure to maintain proper gene expression boundaries at, or
near, the infundibulum.
We observed a significant reduction in the number of Ki67+
proliferating cells in both anterior (RCH) and posterior (infundib-
ulum) regions of the hypothalamus when comparing ShhDhyp
embryos to control littermates at E10.5 (Figures S2A–S2J).
Although this result is consistent with a mitogenic role for Shh
in the hypothalamus, it further suggests that the anteroposterior
patterning defect observed in ShhDhyp embryos is unlikely to be
explained by a selective growth advantage of one hypothalamic
territory over another, since both regions were equally affected.
Nevertheless, the overall reduction in proliferation within the
ventral hypothalamus of ShhDhyp embryos may explain why the
infundibulum failed to develop in these mutants, possibly by
compromising the forces needed to push the two sides of the
evaginating ventral diencephalon together. Alternatively, the
altered pattern of gene expression in the ventral diencephalon
of ShhDhyp embryos may have disrupted reciprocal signals
from Rathke’s pouch that regulate infundibular morphogenesis
(Takuma et al., 1998).
Mouse models of SOD, including Hesx1/, Sox2+/, and
Sox3/ mutants, display hypothalamo-pituitary patterningInc.
Figure 1. The Hypothalamic Source of Shh Is Required for Proper Pituitary Morphology at E12.5
(A, B, D, and E)Whole-mount in situ hybridization forShh andGli1 on bisected brains from control (SBE2cre; Shh+/loxp) andShhDhyp (SBE2cre; Shh/loxp) embryos.
In the hypothalamus of control embryos, Shh is expressed in progenitors of the ventromedial nucleus (VM). Shh is missing from the VM domain of ShhDhyp
embryos, but other forebrain regions, including the zona limitans intrathalamica (ZLI) and POA maintain Shh expression. Gli1 marks Shh-responsive cells in
ventral and anterior hypothalamic nuclei, including the mammillary (MM), premammillary (PM), arcuate (Arc), suprachiasmatic (SCN), anterior hypothalamus
posterior region (AHP), and anterior hypothalamus anterior region (AHA). With the exception of the AHA and MM, all other hypothalamic regions show reduced
Gli1 expression in ShhDhyp embryos.
(C and F) Nkx2.1 immunostaining on midsagittal sections through control and ShhDhyp embryos counterstained with DAPI (blue). Nkx2.1 staining is present in the
ventral hypothalamus andmedial ganglionic eminence (MGE) of ShhDhyp embryos. However, the posterior pituitary (PP) is dysmorphic and ectopically positioned
compared to control embryos.
(G and J) In situ hybridization for Tbx2 on midsagittal sections confirms the ectopic PP in ShhDhyp versus control embryos.
(H and K) Double labeling of the POA and PP with Foxg1 and Tbx2, respectively, shows that the intervening region corresponding to the retrochiasmatic
hypothalamus (RCH) is reduced in ShhDhyp embryos.
(I and L) Nkx2.1 and Lhx3 immunostaining reveals that the anterior pituitary (AP) is duplicated and shifted anteriorly in ShhDhyp mutants. A, anterior; D, dorsal.
See also Figure S1.
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et al., 2006; Rizzoti et al., 2004; Dattani et al., 1998; Dasen
et al., 2001). The anterior expansion of Fgf and Bmp signals
is a common occurrence in these mutants and is postulated
to enhance the recruitment of oral ectoderm to Rathke’s pouch,
resulting in the formation of multiple and ectopic anterior
pituitaries. Consequently, SOD patients often present with defi-Develociencies in one or more pituitary hormones (Kelberman and
Dattani, 2008). Likewise, ShhDhyp mutants displayed significant
reductions in the number of somatotropes, corticotropes, and
thyrotropes in the anterior pituitary at E18.5 (Figures S3B and
S3C). The reduced number of pituitary cell types in ShhDhyp
mutants may be a primary consequence of the loss of
Shh signaling from the diencephalon and/or a secondarypmental Cell 22, 585–596, March 13, 2012 ª2012 Elsevier Inc. 587
Figure 2. Shh Is Required for Proper Anteroposterior Patterning in
the Hypothalamus
(A) Diagram of a midsagittal section through a control E10.5 brain delineating
the approximate expression domains of anteroposterior patterning markers in
the hypothalamus. Bmp4 and Fgf10 are coexpressed in the posterior ventral
midline (blue), while Shh, Six6, and Tcf4mark the anterior ventral midline (red).
(B and C) At E9.5,Bmp4 expression is rostrally expanded (brackets) in ShhDhyp
embryos. Bmp4 is also ectopically expressed in the oral ectoderm of mutants
(arrow).
(D and E) Fgf10 expression is expanded rostrally in ShhDhyp versus control
embryos. Notice that the vertical line extending from the optic recess to the
rostral extent of the Fgf10 expression domain (horizontal line) is truncated in
ShhDhyp compared to control embryos.
(F and G) Shh transcription is repressed in the hypothalamus of ShhDhyp
embryos.
(H and I) Six6 expression is downregulated in the hypothalamus of ShhDhyp
embryos.
(J and K) Tcf4 expression is unaffected in the hypothalamus of ShhDhyp
embryos. A, anterior; D, dorsal.
See also Figures S1 and S2.
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588 Developmental Cell 22, 585–596, March 13, 2012 ª2012 Elsevierconsequence of the patterning alterations in the hypothalamus.
Although our experiments cannot distinguish between these
two possibilities, other studies have implicated Shh signaling
in the proliferation of anterior pituitary progenitors (Treier
et al., 2001; Wang et al., 2010).
Optic Disc Formation Is Dependent on Shh Signaling
from the Hypothalamus
SOD patients also exhibit varying degrees of blindness due to
optic nerve hypoplasia (Kelberman and Dattani, 2008). To deter-
mine whether ShhDhyp embryos were afflicted with a similar eye
defect, we stained retinal ganglion cell (RGC) axons for neurofila-
ment. Unlike control embryos, which showed a tight bundle of
RGC axons exiting the eye at E14.5, the majority of RGC axons
remained trapped in the eye of ShhDhyp embryos, resulting in
a severely hypoplastic optic nerve (Figures 3A and 3B). RGC
axons exit the eye through the optic disc, which forms at the
juncture of the optic stalk and cup (Otteson et al., 1998).
Pax2+, Netrin1+ optic disc cells were not detected in the eyes
of ShhDhyp mutants, although expression of these markers was
detected in the optic stalk (Figures 3C–3F). The absence of optic
disc cells was not due to altered Shh signaling in the eye, as
previously shown (Dakubo et al., 2003), since the expression of
Shh and Gli1, in RGCs and retinal progenitor cells, respectively,
was unaffected in ShhDhyp embryos (Figures 3G–3J).
To elucidate the molecular mechanism responsible for the
optic disc defect in ShhDhyp embryos, we assayed the expres-
sion of genes with known roles in eye development. At E10.5,
Shh and Gli1 were missing from the ventral midline of the dien-
cephalon and optic stalk, respectively, of ShhDhyp embryos
(Figures 3K–3N). Other markers, including Vax1, Pax2, and
Netrin1 maintained their expression in the optic stalk, but were
reduced from the ventral portion of the retina (Figures 3O–3T).
Consequently, the dorsal retinal marker, Pax6, expanded
ventrally in ShhDhyp embryos. These data indicate that the role
of the hypothalamic source of Shh in eye development is mostly
limited to patterning the retina, whereas the earlier source of Shh
in the prechordal plate is required for the separation of the eye
fields and formation of medial structures, such as the optic stalk
(Chiang et al., 1996).
Subtle reductions in the ventral retina domain marked by Pax2
are known to affect themorphogenesis of the optic disc (Dakubo
et al., 2003). Pax2+ cells invaginate in the ventral retina and optic
stalk to generate the optic fissure (curved white arrows in Fig-
ure 3W). The optic disc forms from the population of Pax2+ cells
that invaginate at the juncture between the optic cup and optic
stalk. We examined Pax2+ cells on sections cut parallel to the
surface of the eye in control and ShhDhyp embryos (Figures 3X–
3CC). Although Pax2+ cells successfully invaginated to form
the optic fissure at lateral levels of ShhDhyp embryos (black
arrows in Figures 3AA and 3BB), they failed to invaginate at the
medial extent of the optic cup (note the missing arrowhead in
Figure 3CC). A similar phenotype was observed in Bmp7/
mutants, which lack the optic disc as well as the optic fissure
and show a downregulation in Pax2 expression (Morcillo et al.,
2006). Interestingly, the faint domains of Bmp7 in the ventral
retina, stalk, and midline of the hypothalamus were absent in
ShhDhyp embryos (Figures 3U and 3V). Therefore, the optic disc
defect likely stems from the failure of the hypothalamic sourceInc.
Figure 3. The Optic Disc Fails to Form in ShhDhyp
Embryos
(A–J) Coronal sections through the eyes of control and
ShhDhyp embryos at E14.5. (A and B) RGC axons labeled
with neurofilament (NF) bundle and exit the eye at the optic
disc in control, but not ShhDhyp embryos. (C–F) Pax2 and
Netrin1mark cells of the optic disc (arrowheads) and optic
stalk (arrows). The optic disc is absent in ShhDhypmutants.
(G–J) Shh and Gli1 expression is unaltered in the eyes of
ShhDhyp versus control embryos.
(K–V) Coronal sections through the hypothalamus of E10.5
embryos at the level of the eye. (K–N) The expression of
Shh in the ventral midline of the hypothalamus and Gli1, in
the optic stalk (OS) is lost in ShhDhyp mutants. (O–T) The
expression of Vax1, Pax2, and Netrin 1 is reduced in the
ventral retina (below dotted line) of ShhDhypmutants, but is
preserved in the optic stalk. Pax6 staining in the dorsal
retina (above dotted line) expanded ventrally in ShhDhyp
embryos. (U and V) The weak Bmp7 expression in the
ventral midline of the hypothalamus, optic stalk, and
ventral retina in control embryos is absent in ShhDhyp
mutants.
(W) Diagram of the eye and optic stalk in control and
mutant, tilted to expose the ventral optic fissure (OF). The
fissure and invagination of cells (curved arrows) does not
extend to the stalk in mutants. The level of section in (X)–
(CC) is shown. dOS, dorsal optic stalk; dR, dorsal retina; L,
lens; vOS, ventral optic stalk; vR, ventral retina.
(X–CC) Sections cut parallel to the eye surface at E10.5.
Pax2+ cells invaginate at the lips of the optic fissure
(arrows) in control and ShhDhyp at surface and mid-cup
levels. However, Pax2+ optic disc precursors at the
interface between the eye cup and stalk (arrowhead) fail to
invaginate in ShhDhyp. A, anterior; D, dorsal; L, lateral.
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ventral region of the eye.
Dose-Dependent Regulation ofShh in the Hypothalamus
by SoxB1 Family Members
We next investigated how Shh, Sox2, Sox3, and Hesx1 might be
integrated in a signaling network required for hypothalamo-pitu-
itary development by assessing Shh expression in several
mouse models of SOD. A previous study revealed that the hypo-
thalamic expression of Shh was unaltered in Hesx1/ mutants,
ruling out a role for this homedomain transcription factor in
regulating Shh (Dattani et al., 1998). We therefore focused our
analysis on single and compound mutants in Sox2 and Sox3,
two high-mobility group (HMG)-containing DNA binding proteins
that, along with Sox1, comprise the SoxB1 subfamily (Pevny and
Placzek, 2005).
Sox2 and Sox3 are expressed throughout the ventricular zone
of the CNS where they function to maintain neuronal progenitor
identity (Pevny and Placzek, 2005). Sox2 and Sox3 are coex-
pressed with Shh from the onset of its transcription in the ventralDevelopmental Cell 22, 5diencephalon and continue to share overlap-
ping expression in the RCH at E10.5 (Figures
4A–4D and data not shown).
The intensity of Shh staining in the anterior
hypothalamus of male hemizygous Sox3Y/
mutants (Sox3 is X-linked) was subtly, albeitconsistently, downregulated, especially at its posterior limit
adjacent to the infundibulum (Figures 4E and 4F). This area of
reduced Shh transcription was coincident with an expansion in
the anterior boundary of Fgf10 expression (Figures 4I and 4J).
A similar reduction in the anterior hypothalamic domain of Six6
was observed (Figures 4M and 4N). Taken together with the
results from our analysis of ShhDhypmutants, these data suggest
that the reduced expression of Shh in the hypothalamus of
Sox3Y/ embryos may contribute to the pituitary hypoplasia
described in these animals (Rizzoti et al., 2004).
SOD is typically less severe in Sox3Y/ and Sox2+/ mice
compared to ShhDhyp mutants (Rizzoti et al., 2004; Kelberman
et al., 2006). To determine whether this is due to functional
redundancy between SoxB1 family members, we examined
the expression of hypothalamic markers in various compound
mutants. A very similar pattern of misexpression was observed
for Shh, Fgf10, and Six6 in Sox3+/; Sox2+/ compared to
Sox3Y/ mutants, suggesting that the overall dose rather than
the specific function of Sox2 and Sox3 is important for hypo-
thalamic development (compare Figures 4g, 4k, and 4o to85–596, March 13, 2012 ª2012 Elsevier Inc. 589
Figure 4. SoxB1 Proteins are Dose-Dependent Regulators of Shh Expression in the Anterior Hypothalamus
(A–D) Coexpression of Shh, Sox2, and Sox3 on midsagittal sections through the hypothalamus of wild-type embryos at E10.5.
(E–P) In situ hybridization for Shh (E–H), Fgf10 (I–L), and Six6 (M–P) on midsagittal sections through the hypothalamus of control and SoxB1 mutant embryos at
E10.5. The position of the infundibulum is marked with a dashed line, and arrows point to the posterior boundaries of Shh and Six6 expression. A subtle reduction
in the intensity and posterior demarcation of Shh and Six6 expression was detected in Sox3Y/ and Sox3+/; Sox2+/ mutants, concomitant with an anterior
expansion in Fg10 expression. Sox3Y/; Sox2+/mutants showed a profound loss of Shh and Six6 expression in the anterior hypothalamus and a corresponding
gain in Fgf10.
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heterozygous for Sox2 (Sox3Y/; Sox2+/), the ventral midline of
the anterior hypothalamus was completely devoid of Shh and
Six6 expression and instead was replaced by an expanded
domain of Fgf10 (Figures 4h, 4l, and 4p). The hypothalamic
patterning defect in Sox3Y/; Sox2+/ embryos is highly reminis-
cent of ShhDhyp mutants and is consistent with the notion that
SoxB1 family members function in a dose-dependent manner
to regulate the expression of Shh in the ventral midline of the
anterior hypothalamus. Interestingly, Sox2 also regulates the
postnatal expression of Shh in neuronal stem cell populations
in the hippocampus and lateral ventricle (Favaro et al., 2009).Sox2 and Sox3 Are Direct Regulators of Shh
Transcription
The loss ofShh expression in compound SoxB1mutant embryos
was limited to the hypothalamus, implying a high degree of spec-
ificity to the SoxB1-dependent regulation of Shh transcription
(Figures 4E and 4H). One mechanism by which this might occur
is through the direct binding of SoxB1 factors to SBE2. To
explore this possibility, we scanned the 750 bp SBE2 sequence
for SoxB1 binding sites using the rVista tool and identified
a single site closely matching the consensus sequence that590 Developmental Cell 22, 585–596, March 13, 2012 ª2012 Elsevierwas invariant across multiple phyla (Loots et al., 2002)
(Figure 5A).
Because the SoxB1 binding site was not a perfect match with
the consensus sequence, we evaluated its potential to be bound
by a representative SoxB1 family member in an electrophoretic
mobility shift assay (EMSA). A specific protein-DNA complex
was observed when Cos-1 cell lysates transfected with Flag-
tagged Sox2 were incubated with a radiolabeled probe overlap-
ping the SoxB1 binding site in SBE2 (Figure 5B, lane 2). Further
evaluation of the specificity of the Sox2/SBE2 interaction was
addressed in competition assays using unlabeled probes over-
lapping the SoxB1 motif in SBE2, or a previously characterized
SoxB1 site in the mouse Hesx1 promoter (MHP) (Eroshkin
et al., 2002). Both of these cold probes displaced Sox2 binding
to the radiolabeled SBE2 (WT) probe with equivalent efficiency
(Figure 5B, lanes 3–8). In contrast, an unlabeled mutant SBE2
(DSoxB1) probe was unable to compete efficiently for Sox2
binding (Figure 5B, lanes 9–11).
To determine whether SoxB1 factors are sufficient to stimulate
transcription of an SBE2-driven luciferase reporter construct
(pGL-SBE2 WT), we conducted cotransfection assays. Cos-1
cells transfected with increasing amounts of Sox2 showed
a robust dose-dependent gain in luciferase activity, which was
highly dependent on the presence of the SoxB1 binding siteInc.
Figure 5. Sox2 Binds Directly to SBE2 and Is Necessary for Its Activation
(A) Schematic map showing the distribution of genes/exons (black rectangles) and regulatory elements (colored rectangles) within the 1 Mb genomic region
upstream of Shh on mouse chromosome 5. The SoxB1 binding site (red) in SBE2 is highly conserved across species.
(B) EMSAs performed with Cos-1 cell extracts transfected with pcDNA3-Flag (lane 1) or pcDNA3-Flag-Sox2 (lanes 2–11) expression vectors, incubated with
a radiolabeled SBE2wild-type (WT) probe. The arrow points to the specific protein/DNA complex. Increasing concentrations of unlabeledWT probes overlapping
the SoxB1 site in SBE2 (lanes 3–5) or MHP (lanes 6–8) effectively competed for Sox2 binding, whereas the mutated SBE2 (DSoxB1) probe did not (lanes 9–11).
(C) Sox2 regulates SBE2 activity in vitro. Cos-1 cells were cotransfected with either WT (blue) or DSoxB1 (magenta) versions of SBE2-luciferase constructs and
increasing amounts of pcDNA3-Flag-Sox2 plasmids. Sox2 activated SBE2-luc (WT) in a dose-dependent manner, but not SBE2-luc (DSoxB1). Each point on the
curve represents an average of three experiments performed in triplicate.
(D) Human mutations in Sox2 affect SBE2 binding and/or activation. Top: Schema of Sox2 protein showing amino acid substitutions arising from point mutations
in either the HMG DNA-binding or transactivation domains. Middle: Cos-1 cell lysates transfected with pcDNA3-Flag (lane 1), pcDNA3-Flag-Sox2 (lane 2), or
pcDNA3-Flag-muSox2 (lanes 3–5) were analyzed for binding to a radiolabeled SBE2(WT) probe. No complex formation was observed for the L97P mutant (lane
4), whereas the A191T and Q177X mutants (lanes 3 and 5) showed normal or increased DNA binding, respectively. aFlag immunoblot demonstrates that WT and
mutant Sox2 proteins were expressed at equivalent levels, although the size of Q177X is smaller than WT. Bottom: Mutant Sox2 proteins showed significantly
impaired transactivation of the SBE2 (WT) luciferase reporter construct. Each bar represents the average of three experiments performed in triplicate. Asterisk
represents a statistically significant difference from WT (p < 0.05).
(E) ChIP from embryos using anti-Sox2, -Sox3, or -IgG antibodies. Quantitative PCR results from three independent experiments revealed SBE2 enrichment in
Sox2 and Sox3 bound chromatin isolated from forebrain and posterior trunk regions of E10.5 mouse embryos (*p < 0.01, Student’s t test). A control sequence
6.5 kb downstream of SBE2 was not enriched in Sox2- or Sox3-bound chromatin. Error bars in all graphs represent SEM.
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Figure 6. SBE2 Activity in the Hypothalamus Is Dependent on
a Highly Conserved SoxB1-Binding Site
X-gal staining of representative transgenic embryos carrying either (A, C, E,
and G) or SoxB1-deleted (DSoxB1) (B, D, F, and H) SBE2-lacZ reporter
constructs at E10.5. The dashed lines in (A) and (B) show the plane of section in
(C–H). The number of embryos showing representative reporter activity over
the total number of transgenic embryos is indicated for each construct in
(A and B).
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shown). Our finding that SoxB1 factors are potent and direct
activators of SBE2-mediated transcription afforded us with an
assay to assess the mechanisms by which SOD causing muta-
tions in these genes might affect Shh transcription. It should be
noted that mutations in Sox2 are not strictly associated with
SOD, but also cause a range of other developmental disorders,
including anopthalmia, developmental delay, esophageal
atresia, and genital defects (Kelberman and Dattani, 2008). A
previously described mutation in the HMG domain of Sox2
(L97P) impeded its binding to SBE2 (Figure 5D) (Ragge et al.,
2005). Two other Sox2 variants carrying point mutations in the
transactivation domain showed either no effect on DNA binding
(A191T) or enhanced binding to SBE2 (Q177X), the mechanism
for which is unclear (Kelberman et al., 2006; Fantes et al.,
2003). Interestingly, none of the Sox2 variants activated SBE2-
dependent luciferase expression to a level comparable to wild-
type (WT) Sox2 (Figure 5D). These findings indicate that
disease-causing variants in Sox2 failed to bind and/or activate
SBE2.
We next performed chromatin immunoprecipitation (ChIP)
experiments to determine whether SoxB1 binding to SBE2
occurred in vivo. A significant enrichment of SBE2 was detected
in Sox2 and Sox3-bound chromatin isolated from embryonic
brain extracts at E10.5 (Figure 5E). No such enrichment was de-
tected in chromatin pulled down with an antibody against Sox9
(data not shown). Moreover, the presence of a DNA sequence
6.5 kb downstream of SBE2 was not enhanced in Sox2 or
Sox3-bound chromatin, suggesting that the recruitment of
SoxB1 factors to SBE2 was specific. Unexpectedly, a slight
enrichment in SBE2 sequence was also observed in Sox2 bound
chromatin isolated from the trunk region of the embryo. The
significance of this finding is unclear as SBE2 is not active in
posterior regions of the embryo. Nonetheless, these data indi-
cate that Sox2 and Sox3 are recruited to SBE2 in the embryonic
forebrain at a stage when Shh is dependent on SoxB1 factors for
its expression.
To address the in vivo significance of the SoxB1 binding site,
we performed transgenic reporter assays with constructs con-
taining either WT or mutant (DSoxB1) versions of SBE2 lacking
the SoxB1motif. Embryos carrying the SBE2 (WT) lacZ construct
showed a pattern of X-gal staining in the ventral diencephalon
that is both typical for this enhancer and the endogenous expres-
sion of Shh (n = 3/4; Figures 6A, 6C, 6E, and 6G) (Jeong et al.,
2006). In contrast, embryos carrying the mutated SBE2
(DSoxB1) lacZ construct displayed a truncated pattern of X-gal
staining that consistently failed to extend into the anterior hypo-
thalamic domain, including the area showing reduced Shh
expression in SoxB1 mutant embryos (n = 12/13; Figures 5B,
5D, 5F, and 5H). Thus, the putative SoxB1 binding site in SBE2
is essential for transcriptional activity in the hypothalamus.
DISCUSSION
Our results identify unique roles for the hypothalamic source of
Shh in regulating eye and pituitary morphogenesis. The pheno-
types shared between ShhDhyp embryos and other mouse
models of SOD suggest that reduced Shh signaling from the
hypothalamus underlies the pathogenesis of this disorder. In592 Developmental Cell 22, 585–596, March 13, 2012 ª2012 Elsevieragreement with this hypothesis, we show that the hypothalamic
expression of Shh is directly dependent on Sox2 and Sox3, two
genes that are mutated in humans and mice with SOD. Thus,
SOD represents a congenital brain anomaly with a later manifes-
tation compared to HPE, due to differences in the timing and
location of Shh signal attenuation.
The unique functions of Shh in the prechordal plate versus the
hypothalamus distinguish HPE from SOD. This is particularly
apparent by the distinct sets of genetic variants responsible for
each of these heterogeneous disorders (Kelberman and Dattani,
2008; Geng and Oliver, 2009). The prechordal plate has
long been regarded as an important signaling center for fore-
brain development. Surgical removal of the prechordal plate
in a variety of experimental organisms results in alobar HPE,Inc.
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of the cerebral hemispheres, eyes, nasal placodes, and other
craniofacial structures (Li et al., 1997; Pera and Kessel, 1997;
Aoto et al., 2009). A similar HPE phenotype is observed in
humans and mice lacking Shh or other genes required for pre-
chordal plate specification (Geng and Oliver, 2009). Shh is only
expressed in the prechordal plate for a relatively brief period,
lasting approximately 24 hr from E7.75 to E8.75 (Echelard
et al., 1993). During this time, Shh signals to the overlying neuro-
epithelium to fulfill three crucial patterning events: (1) bifurcation
of the telencephalic vesicles, (2) induction of the hypothalamus,
and (3) formation of the bilateral optic stalks (Chiang et al., 1996).
Moreover, Shh is required to maintain the viability of prechordal
plate cells for their subsequent development into ventral cranial
mesoderm and foregut endoderm (Aoto et al., 2009).
Although Shh/ embryos reveal the importance of Shh
signaling from the prechordal plate, the HPE phenotype is further
enhanced by the loss of Shh from secondary and tertiary
signaling centers, including the ventral hypothalamus, ventral
telencephalon (medial ganglionic eminence), oral ectoderm,
and pharyngeal endoderm, all of whichmake important contribu-
tions to brain and craniofacial development (Shimogori et al.,
2010; Helms et al., 2005; Xu et al., 2010; Flandin et al., 2011).
As mentioned, Shh expression in the hypothalamus is depen-
dent on Shh signaling from the prechordal plate (Dale et al., 1997;
Manning et al., 2006). Members of the Gli family of zinc finger
containing transcriptional regulators mediate this homeogenetic
(like-by-like) signaling cascade. Gli2/; Gli3/ embryos show
a pronounced downregulation of Shh expression in the hypotha-
lamic region of the neural tube (Motoyama et al., 2003). This
Gli-dependent activation of Shh transcription in the ventral
hypothalamus is not direct, since Gli binding sites were not iden-
tified in SBE2 (Jeong et al., 2006). Instead, it is the combined
action of Nkx2.1, Six3, Sox2, and Sox3 that is required for the
initiation of Shh transcription in the hypothalamus (Sussel
et al., 1999; Geng et al., 2008; Jeong et al., 2008). The precise
mechanism by which these transcription factors function, either
independently or in a complex, to regulate Shh expression is
unclear. Nevertheless, our current and previous studies show
that SoxB1 and Six3 factors are direct regulators of SBE2 activity
(Jeong et al., 2008).
Bmp signaling from the prechordal plate in chick embryos
further elaborates on the identity of ventral hypothalamic cells
by activating Tbx2, which in turn represses Shh expression in
the ventral midline of the tuberomamillary region (Dale et al.,
1997; Manning et al., 2006). This explains why Shh expression
is split into bilateral stripes running through the posterior portion
of the hypothalamus. Continuous Bmp signaling is also likely
responsible for establishing the ventral midline domains of
Bmp4, Fgf8, and Fgf10 in the posterior hypothalamus (Manning
et al., 2006). Hence, an expression boundary is created at the
point where Bmp/Fgf in the ventral midline of the posterior hypo-
thalamus abuts the expression of Shh in the ventral midline of the
anterior hypothalamus. The positioning of this boundary is
essential for proper pituitary morphogenesis, as it delineates
the anterior limit of a set of reciprocal signaling interactions
between the infundibulum and oral ectoderm, from where the
posterior and anterior lobes of the pituitary derive, respectively
(Zhu et al., 2007).DeveloThe boundary between Shh and Bmp/Fgf is shifted anteriorly
in several mouse models of SOD. In ShhDhyp- and SoxB1-defi-
cient embryos, the rostral expansion of Bmp4 and Fgf10 is due
to the loss of Shh on the anterior side of the infundibulum. Inter-
estingly, a similar function was previously ascribed to Hedgehog
(Hh) in zebrafish. However, in this scenario, Hh signaling was
required to prevent the entire anterior hypothalamic domain,
rather than just the ventral midline, from adopting a posterior
hypothalamic fate (Mathieu et al., 2002). Nevertheless, the
general principle that Shh regulates anteroposterior patterning
within the hypothalamus is likely conserved across phyla.
Tcf4/, Noggin/, andWnt5a/ mouse mutants also show
alterations in the positioning of the infundibulum, with associated
pituitary dysmorphology (Davis and Camper, 2007; Brinkmeier
et al., 2007; Potok et al., 2008). Consequently, these genes are
good candidates for mutation in humans with SOD. In the case
of Noggin, a secreted Bmp4 inhibitor, its absence results in
a rostral expansion in the Bmp4 signaling domain and concom-
itant reduction in Shh expression in the anterior hypothalamus
(Davis and Camper, 2007). Therefore, the antagonism between
Shh and Bmp signaling that plays an essential role in regulating
dorsoventral identity in the neural tube may also be instrumental
in regulating anteroposterior patterning in the hypothalamus.
Mouse embryos carrying mutations in Vax1, a homeodomain
containing transcriptional regulator, also show phenotypes that
overlap with SOD, including eye and pituitary defects (Bertuzzi
et al., 1999; Bharti et al., 2011). Moreover, Shh from the prechor-
dal plate regulates the expression of Vax1 and Vax2 in both the
developing eye and ventral diencephalon (Take-uchi et al.,
2003; Kim and Lemke, 2006). However, despite the seemingly
linear relationship between prechordal plate Shh and Vax1
expression in early brain patterning, differences in the molecular
mechanisms underlying the Vax1/ and ShhDhypmutant pheno-
types point to a divergence in their regulatory relationship and-
function at later stages. For instance, the ectopic pituitary that
forms in Vax1/ embryos appears to result from the failure to
directly repress Fgf10 transcription in only a relatively small
patch (compared to ShhDhyp embryos) of the most anterior
region of the diencephalon, with no obvious consequence to
the neuroepithelial expression of Bmp4, Six6, or Shh (Bharti
et al., 2011). Likewise, Vax1 continues to be expressed in the an-
terior hypothalamus of ShhDhypmutants (data not shown). Taken
together, these results suggest that Vax1 and Shh repress Fgf10
in the anterior hypothalamus through distinct mechanisms.
The reduction of Shh expression in the ventral midline of the
anterior hypothalamus can explain each of the primary defects
observed in mouse models of SOD. Portions of the hypothal-
amus, pituitary and eye are dependent on the ventral midline
source of Shh in the anterior hypothalamus for specific aspects
of their development. Whereas ShhDhyp embryos may reflect an
extreme example of SOD that is incompatible with life, subtle
reductions in Shh expression, such as those observed in Sox2
and Sox3 mutants may be more typical of human SOD cases
that survive postnatally.
It is intriguing to speculate that the phenotypic variability that is
commonly associated with SOD in humans may be due to subtle
differences in the timing, extent, and duration of Shh downregu-
lation, resulting from either genetic or environmental means.
Support for this supposition is drawn from studies assessingpmental Cell 22, 585–596, March 13, 2012 ª2012 Elsevier Inc. 593
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togenic agents (Lipinski et al., 2010). For instance, fetal alcohol
syndrome shares a similar spectrum of defects with HPE and
SOD, depending on the gestational period of ethanol exposure
(Lipinski et al., 2010; Coulter et al., 1993; Hellstro¨m, 1999). Shh
appears to be an important target of ethanol judging from the
loss of its expression in the prechordal plate, and subsequent
HPE phenotype, in mouse embryos subjected to ethanol during
gastrulation (Aoto et al., 2008). It will be important to determine
whether embryos exposed to ethanol later in development reca-




Cos-1 cells were transfected with pcDNA3-Flag, pcDNA3-Flag-Sox2, or
pcDNA3-Flag-muSox2 using FuGENE 6 (Roche Applied Science) according
to the manufacturer’s instructions. Forty-eight hr after transfection, whole
cell lysates were prepared in a radio immunoprecipitation assay buffer con-
taining 50 mM Tris-HCl (pH 7.5) 150 mM NaCl, 1% Triton X-100, and 0.5%
sodium deoxycholate and protease inhibitor cocktail (Roche Applied Science).
EMSA was performed as described (Jeong et al., 2008). The sequence of the




Transient Transfection and Dual Reporter Assays
Cos-1 cells were cultured under standard conditions in Dulbecco’s modified
Eagle’s medium (DMEM) (GIBCO BRL) supplemented with 10% fetal bovine
serum and transfected at 50%–70% confluency using FuGENE 6 (Roche
Applied Science). We mixed 1 mg of an SBE2-luciferase reporter construct
pGL4.23[luc2/minP] (Promega) with 0.25–4 mg of pcDNA3-Flag-Sox2 expres-
sion plasmid or empty vector for compensation, and 5 ng of pRL-TK vector
(Promega) as an internal control and applied to cells grown in a 3 cmdish. Cells
were harvested 48 hr after transfection and assayed for firefly and renilla-lucif-
erase activities (Dual Luciferase assay system, Promega). Enhancer activity
was expressed as fold induction relative to that of cells transfected with the
empty pcDNA3 vector. At least three independent experiments were per-
formed for each construct in triplicate.
Chromatin Immunoprecipitation
Approximately 10–15 embryos at E10.5 were harvested in DMEM (with 10%
fetal bovine serum), pooled into head and trunk fractions, cut into small pieces,
and fixedwith 1%paraformaldehyde for 15minwith shaking. Crosslinkingwas
blocked by treating samples with 100 mM glycine for 15 min. Tissues were
homogenized with a B dounce pestle in cell lysis buffer (5 mM PIPES [pH
8.0], 85 mM KCl, 0.5% NP-40) with protease inhibitor cocktail, then nuclei
were spun down and resuspended in nuclei lysis buffer (50 mM Tris-HCl [pH
8.1], 10 mM EDTA, 1% SDS). Chromatin was sonicated and diluted in buffer
(0.5% Triton X-100, 2mMEDTA, 20mMTris-HCl [pH 8.1], 150mMNaCl). After
preclearing with protein A and G agarose beads (Upstate), the chromatin was
incubated overnight with 4 mg of anti-Sox2 (Abcam), anti-Sox3 (R&D Systems),
or anti-immunoglobulin G (IgG) (Santa Cruz Biotechnology) antibodies, fol-
lowed by 2 hr of incubation with protein A and G agarose beads, which were
washed overnight in dilution buffer. Beads were washed twice with low-salt
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl [pH 8.1],
150 mM NaCl), twice with high-salt buffer (0.1% SDS, 1% Triton X-100,
2 mM EDTA, 20 mM Tris-HCl [pH 8.1], 500 mM NaCl), twice again with low-
salt buffer, once with Li buffer (0.25 M LiCl, 1% NP-40, 1% deoxycholate,
1 mM EDTA, 10 mM Tris-HCl [pH 8.1]), and once with TE. After elution with
100 mM NaHCO3 and 1% SDS and decrosslinking, DNA was purified with
phenol/chloroform/isoamylalcohol and subjected to quantitative PCR
as described (Jeong et al., 2008) with the following primer sets: SBE2: (F)
50-CATATTCTAACCAGTTGGCCCTA-30, (R) 50-TTGTCCACATGATCCATTT594 Developmental Cell 22, 585–596, March 13, 2012 ª2012 ElsevierCA-30; 6.5 kb 30 of SBE2: (F) 50-CACATCAGCATCCTAGCCTAC-30, (R)
50-GGTACATTTCTTGTAGCTTCG-30.
Plasmid Construction
SBE2 reporter constructs were generated by cloning a 750 bp SBE2
sequence into a vector containing the Shh minimal promoter, lacZ gene, and
SV40 poly(A) signal. A construct containing a deletion of the SoxB1-binding
site (TTGTTTG) was generated by ligating two PCR products immediately
flanking this site that were amplified with the following primer sets: E355
(50-GCAGCTGGATCCACAAAGCGACTTAGAGAATCTT-30) and E360 (50- GCA
GCTTCTAGATAGGGCCACTGGTTAGAATATG-30); E361 (50-GCAGCTTCTA
GAGCTTTGAATCACTCGTTTCAATA-30) and E343 (50-GCAGCTGCGGCCG
CACAGTCATTAGAGGCAAACAG-30). The cloning of full-length wild-type or
mutant versions of human Sox2 into the pCMV/SV-Flag expression vector
was described previously (Kelberman et al., 2006).
Mouse Lines
Transient transgenic embryos were generated by pronuclear injection of SBE2
reporter constructs into fertilized eggs derived from the (BL63 SJL) F1 mouse
strain (The Jackson Laboratory, Bar Harbor, ME). Sox2; Sox3 compound
mutant embryos were produced by crossing Sox2+/ males with Sox3+/
females (Rizzoti and Lovell-Badge, 2007). The SBE2-cre line was generated
by pronuclear injection of a construct containing cre cloned downstream of
SBE2 and a minimal Shh promoter. Stable lines were screened by in situ
hybridization for cre expression in the SBE2 domain within the ventral dien-
cephalon. The Shh+/ and Shhfl/fl (Shhtm2Amc) mouse strains were procured
from The Jackson Laboratory (Bar Harbor, ME).
Whole-Mount b-Galactosidase Staining and Whole-Mount In Situ
Hybridization
The activity of b-galactosidase was detected using X-gal (Sigma) as substrate.
Whole-mount RNA in situ hybridization was performed using digoxygenin-
UTP-labeled riboprobes according to a previously described protocol (Jeong
et al., 2006). Stained embryos were dehydrated in methanol, cleared in benzyl
alcohol:benzyl benzoate (1:1), and photographed. Representative embryos
were rehydrated, sunk in 30% sucrose overnight, embedded in optimal cutting
temperature embedding medium (OCT), quick-frozen on dry ice, and cryosec-
tioned at 20 mm.
Immunohistochemistry and Section In Situ Hybridization
Embryoswere collected at specified developmental stages (plugday= 0.5) and
fixed in 4% paraformaldehyde at 4C for either 90 min, for immunohistochem-
istry, or overnight, for in situ hybridization. Embryoswerewashed extensively in
PBS, sunk in 30% sucrose overnight at 4C, embedded in OCT, quick-frozen
on dry ice, and cryosectioned at 20 mm. Primary antibodies used for immuno-
histochemistry and dilutions were as follows: Shh (5E1; 1:100); Lhx3 (1:100);
Pax6 (1:100); Neurofilament (1:250) (Developmental Studies Hybridoma
Bank, University of Iowa, Iowa City, IA); Nkx2.1 (1:1000; Dr. Carole Mendelson,
University of Texas SouthwesternMedical School, Dallas, TX), Pax2 (1:250; In-
vitrogen), Tcf4 (1:200; Exalpha Biologicals, Inc.), Sox2 (1:250; Millipore), Sox3
(1:100; R&D Systems). Detection of primary antibodies was achieved using
Cy3-(Jackson ImmunoResearch Laboratories) or Alexa 488- (Molecular
Probes) conjugated secondary antibodies. Vector Labs’ Vectastain Elite ABC
Kit (rabbit IgG) and ImmPACT DAB peroxidase substrate were used to detect
Pax2 staining on sagittal sections through the eye. Section in situ hybridization
was performed as described (Nissim et al., 2007). At least 3–5 control and
mutant embryos were evaluated for each antibody or in situ probe.
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